An Observer-blind, Dose Ranging Safety and Immunogenicity Study of GSK Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007377/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the safety and immunogenicity of different
formulations of GSK Biologicals' influenza candidate vaccine GSK1557484A, in children 6-35
months of age.
提供机构：
Vivli
创建时间：
2021-08-26
